Alnylam Pharmaceuticals, Inc. (ALNY)
USD 240.01
(0.94%)
USD 240.01
(0.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.8 Billion USD | 8.85% |
| 2022 | 1.65 Billion USD | 17.05% |
| 2021 | 1.41 Billion USD | 13.64% |
| 2020 | 1.24 Billion USD | 9.62% |
| 2019 | 1.13 Billion USD | 27.75% |
| 2018 | 887.77 Million USD | 50.47% |
| 2017 | 590 Million USD | 25.07% |
| 2016 | 471.74 Million USD | 39.94% |
| 2015 | 337.1 Million USD | 43.59% |
| 2014 | 234.77 Million USD | 67.57% |
| 2013 | 140.1 Million USD | 6.81% |
| 2012 | 131.18 Million USD | -4.65% |
| 2011 | 137.57 Million USD | -4.54% |
| 2010 | 144.11 Million USD | -3.05% |
| 2009 | 148.64 Million USD | 19.88% |
| 2008 | 123.99 Million USD | -13.93% |
| 2007 | 144.07 Million USD | 116.88% |
| 2006 | 66.43 Million USD | 35.06% |
| 2005 | 49.18 Million USD | 34.61% |
| 2004 | 36.54 Million USD | 77.18% |
| 2003 | 20.62 Million USD | 388.49% |
| 2002 | 4.22 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 573.89 Million USD | -9.33% |
| 2024 Q1 | 471.79 Million USD | 0.32% |
| 2024 Q2 | 542.53 Million USD | 15.0% |
| 2023 Q4 | 470.26 Million USD | 3.96% |
| 2023 Q3 | 452.35 Million USD | -2.34% |
| 2023 Q2 | 463.21 Million USD | 11.83% |
| 2023 Q1 | 414.22 Million USD | -12.31% |
| 2023 FY | 1.8 Billion USD | 8.85% |
| 2022 Q4 | 472.38 Million USD | -1.84% |
| 2022 Q1 | 324.36 Million USD | -21.92% |
| 2022 Q2 | 375.69 Million USD | 15.83% |
| 2022 FY | 1.65 Billion USD | 17.05% |
| 2022 Q3 | 481.23 Million USD | 28.09% |
| 2021 Q2 | 327.95 Million USD | -1.44% |
| 2021 Q3 | 336.64 Million USD | 2.65% |
| 2021 FY | 1.41 Billion USD | 13.64% |
| 2021 Q4 | 415.43 Million USD | 23.4% |
| 2021 Q1 | 332.75 Million USD | -0.6% |
| 2020 Q2 | 282.89 Million USD | -4.54% |
| 2020 Q4 | 334.76 Million USD | 1.67% |
| 2020 Q3 | 329.25 Million USD | 16.39% |
| 2020 FY | 1.24 Billion USD | 9.62% |
| 2020 Q1 | 296.33 Million USD | -17.13% |
| 2019 Q4 | 357.57 Million USD | 27.19% |
| 2019 FY | 1.13 Billion USD | 27.75% |
| 2019 Q2 | 276.65 Million USD | 26.48% |
| 2019 Q1 | 218.73 Million USD | -8.76% |
| 2019 Q3 | 281.14 Million USD | 1.62% |
| 2018 Q3 | 256.49 Million USD | 15.4% |
| 2018 Q4 | 239.72 Million USD | -6.54% |
| 2018 FY | 887.77 Million USD | 50.47% |
| 2018 Q1 | 169.3 Million USD | -8.6% |
| 2018 Q2 | 222.26 Million USD | 31.28% |
| 2017 FY | 590 Million USD | 25.07% |
| 2017 Q2 | 136.4 Million USD | 8.72% |
| 2017 Q4 | 185.22 Million USD | 29.62% |
| 2017 Q3 | 142.89 Million USD | 4.76% |
| 2017 Q1 | 125.47 Million USD | -5.58% |
| 2016 Q4 | 132.88 Million USD | 10.44% |
| 2016 Q2 | 101.15 Million USD | -13.81% |
| 2016 FY | 471.74 Million USD | 39.94% |
| 2016 Q1 | 117.37 Million USD | 17.3% |
| 2016 Q3 | 120.32 Million USD | 18.95% |
| 2015 Q2 | 81.62 Million USD | 15.36% |
| 2015 Q4 | 100.06 Million USD | 18.2% |
| 2015 Q3 | 84.65 Million USD | 3.71% |
| 2015 FY | 337.1 Million USD | 43.59% |
| 2015 Q1 | 70.75 Million USD | 1.47% |
| 2014 Q2 | 56.19 Million USD | 6.66% |
| 2014 Q3 | 56.17 Million USD | -0.03% |
| 2014 Q4 | 69.73 Million USD | 24.14% |
| 2014 FY | 234.77 Million USD | 67.57% |
| 2014 Q1 | 52.68 Million USD | 30.28% |
| 2013 Q3 | 41.22 Million USD | 37.42% |
| 2013 Q1 | 28.44 Million USD | -10.67% |
| 2013 Q2 | 29.99 Million USD | 5.46% |
| 2013 FY | 140.1 Million USD | 6.81% |
| 2013 Q4 | 40.43 Million USD | -1.91% |
| 2012 Q4 | 31.84 Million USD | -8.77% |
| 2012 Q1 | 31.48 Million USD | -7.52% |
| 2012 Q3 | 34.9 Million USD | 5.93% |
| 2012 FY | 131.18 Million USD | -4.65% |
| 2012 Q2 | 32.95 Million USD | 4.67% |
| 2011 Q4 | 34.04 Million USD | 2.44% |
| 2011 Q2 | 33.73 Million USD | -7.77% |
| 2011 Q1 | 36.57 Million USD | 8.84% |
| 2011 FY | 137.57 Million USD | -4.54% |
| 2011 Q3 | 33.22 Million USD | -1.49% |
| 2010 Q3 | 36.39 Million USD | -4.83% |
| 2010 FY | 144.11 Million USD | -3.05% |
| 2010 Q1 | 35.87 Million USD | 3.39% |
| 2010 Q2 | 38.24 Million USD | 6.62% |
| 2010 Q4 | 33.6 Million USD | -7.68% |
| 2009 FY | 148.64 Million USD | 19.88% |
| 2009 Q4 | 34.69 Million USD | 2.35% |
| 2009 Q3 | 33.89 Million USD | -27.89% |
| 2009 Q2 | 47.01 Million USD | 42.3% |
| 2009 Q1 | 33.03 Million USD | 2.55% |
| 2008 Q1 | 26.14 Million USD | 23.79% |
| 2008 Q4 | 32.21 Million USD | 11.22% |
| 2008 Q3 | 28.96 Million USD | -20.99% |
| 2008 FY | 123.99 Million USD | -13.93% |
| 2008 Q2 | 36.66 Million USD | 40.21% |
| 2007 Q2 | 24.08 Million USD | -22.83% |
| 2007 Q4 | 21.12 Million USD | -68.78% |
| 2007 FY | 144.07 Million USD | 116.88% |
| 2007 Q1 | 31.21 Million USD | 83.9% |
| 2007 Q3 | 67.65 Million USD | 180.88% |
| 2006 Q3 | 16.81 Million USD | -1.84% |
| 2006 Q4 | 16.97 Million USD | 0.93% |
| 2006 Q1 | 15.51 Million USD | -5.8% |
| 2006 FY | 66.43 Million USD | 35.06% |
| 2006 Q2 | 17.13 Million USD | 10.42% |
| 2005 Q1 | 8.32 Million USD | 1.8% |
| 2005 Q4 | 16.46 Million USD | 36.3% |
| 2005 FY | 49.18 Million USD | 34.61% |
| 2005 Q3 | 12.08 Million USD | -1.86% |
| 2005 Q2 | 12.31 Million USD | 47.91% |
| 2004 Q1 | 13.46 Million USD | 165.29% |
| 2004 Q2 | 7.1 Million USD | -47.23% |
| 2004 FY | 36.54 Million USD | 77.18% |
| 2004 Q4 | 8.17 Million USD | 4.93% |
| 2004 Q3 | 7.79 Million USD | 9.67% |
| 2003 FY | 20.62 Million USD | 388.49% |
| 2003 Q4 | -20.62 Million USD | 0.0% |
| 2003 Q2 | 1.78 Million USD | 40.92% |
| 2003 Q3 | - USD | -100.0% |
| 2003 Q1 | 1.26 Million USD | 0.0% |
| 2002 FY | 4.22 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Agenus Inc. | 78.18 Million USD | -2202.369% |
| Immix Biopharma, Inc. | 16.14 Million USD | -11052.025% |
| Keros Therapeutics, Inc. | 169.27 Million USD | -963.382% |
| Caribou Biosciences, Inc. | 150.53 Million USD | -1095.768% |
| Madrigal Pharmaceuticals, Inc. | 380.49 Million USD | -373.083% |
| MiMedx Group, Inc. | 229.72 Million USD | -683.565% |
| Novavax, Inc. | 779.12 Million USD | -131.036% |
| Seer, Inc. | 110.49 Million USD | -1529.162% |
| Acelyrin, Inc. | 422.06 Million USD | -326.49% |
| Xeris Biopharma Holdings, Inc. | 168.43 Million USD | -968.691% |
| IO Biotech, Inc. | 91.44 Million USD | -1868.506% |
| Ardelyx, Inc. | 169.93 Million USD | -959.252% |
| C4 Therapeutics, Inc. | 159.78 Million USD | -1026.538% |
| Corbus Pharmaceuticals Holdings, Inc. | 13.9 Million USD | -12841.103% |
| Fortress Biotech, Inc. | 200.19 Million USD | -799.154% |
| Fortress Biotech, Inc. | 200.19 Million USD | -799.154% |
| Geron Corporation | 70.44 Million USD | -2455.417% |
| Arrowhead Pharmaceuticals, Inc. | 445.73 Million USD | -303.839% |
| HOOKIPA Pharma Inc. | 32.74 Million USD | -5397.041% |
| Incyte Corporation | 1.19 Billion USD | -51.203% |
| Innoviva, Inc. | 132.15 Million USD | -1262.093% |
| Kintara Therapeutics, Inc. | 8.45 Million USD | -21199.976% |
| ChromaDex Corporation | 56.37 Million USD | -3092.786% |
| Ligand Pharmaceuticals Incorporated | 84.32 Million USD | -2034.721% |
| MEI Pharma, Inc. | 34.78 Million USD | -5074.82% |
| NextCure, Inc. | 67.63 Million USD | -2561.355% |
| Onconetix, Inc. | 34.9 Million USD | -5056.67% |
| Oncternal Therapeutics, Inc. | 12.74 Million USD | -14022.556% |
| GlycoMimetics, Inc. | 39.28 Million USD | -4482.023% |
| IDEAYA Biosciences, Inc. | 157.81 Million USD | -1040.622% |
| Vaxcyte, Inc. | 468.04 Million USD | -284.595% |
| Precigen, Inc. | 84.18 Million USD | -2038.322% |
| Pharming Group N.V. | 225.49 Million USD | -698.285% |
| ContextLogic Inc. | 387 Million USD | -365.132% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -9409.541% |
| Pyxis Oncology, Inc. | 82.19 Million USD | -2089.962% |
| Rigel Pharmaceuticals, Inc. | 130.26 Million USD | -1281.867% |
| AlloVir, Inc. | 180.93 Million USD | -894.877% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -7305.645% |
| Marinus Pharmaceuticals, Inc. | 160.54 Million USD | -1021.254% |
| Salarius Pharmaceuticals, Inc. | 12.89 Thousand USD | -13960354.475% |
| Summit Therapeutics Inc. | 87.68 Million USD | -1952.849% |
| Syndax Pharmaceuticals, Inc. | 229.95 Million USD | -682.792% |
| Sensei Biotherapeutics, Inc. | 37.06 Million USD | -4756.629% |
| Senti Biosciences, Inc. | 94.7 Million USD | -1800.703% |
| BioXcel Therapeutics, Inc. | 171.9 Million USD | -947.144% |
| Alaunos Therapeutics, Inc. | 29.46 Million USD | -6008.321% |
| Entrada Therapeutics, Inc. | 132.17 Million USD | -1261.877% |
| Psyence Biomedical Ltd. | 2.75 Million USD | -65319.058% |
| Outlook Therapeutics, Inc. | 53.12 Million USD | -3288.262% |
| Chimerix, Inc. | 93.38 Million USD | -1827.487% |
| PDS Biotechnology Corporation | 43.04 Million USD | -4081.789% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -10211.399% |
| CRISPR Therapeutics AG | 463.49 Million USD | -288.368% |
| Wave Life Sciences Ltd. | 181.3 Million USD | -892.858% |
| Phathom Pharmaceuticals, Inc. | 167.82 Million USD | -972.569% |
| Pieris Pharmaceuticals, Inc. | 72.56 Million USD | -2380.585% |
| CARGO Therapeutics, Inc. Common Stock | 96.71 Million USD | -1761.298% |
| Precision BioSciences, Inc. | 92.46 Million USD | -1846.791% |
| Dyadic International, Inc. | 9.15 Million USD | -19567.003% |
| Elevation Oncology, Inc. | 45.44 Million USD | -3860.966% |
| Eton Pharmaceuticals, Inc. | 22.25 Million USD | -7989.071% |
| Akebia Therapeutics, Inc. | 201.11 Million USD | -795.041% |
| Aptorum Group Limited | 10.56 Thousand USD | -17036252.451% |
| Bicycle Therapeutics plc | 216.92 Million USD | -729.819% |
| Telomir Pharmaceuticals, Inc. Common Stock | 3.94 Million USD | -45563.092% |
| Clearside Biomedical, Inc. | 32.71 Million USD | -5402.25% |
| Inhibikase Therapeutics, Inc. | 6.73 Million USD | -26639.096% |
| GT Biopharma, Inc. | 13.57 Million USD | -13159.141% |
| Alkermes plc | 996.24 Million USD | -80.684% |
| Verrica Pharmaceuticals Inc. | 70.59 Million USD | -2449.878% |
| Jaguar Health, Inc. | 42.01 Million USD | -4184.329% |
| VistaGen Therapeutics, Inc. | 34.08 Million USD | -5181.094% |
| AbCellera Biologics Inc. | 275.23 Million USD | -554.016% |
| PureTech Health plc | 144.59 Million USD | -1144.881% |
| TransCode Therapeutics, Inc. | 19.41 Million USD | -9169.818% |
| Sangamo Therapeutics, Inc. | 228.68 Million USD | -687.153% |
| SELLAS Life Sciences Group, Inc. | 37.86 Million USD | -4653.389% |
| Barinthus Biotherapeutics plc | 84.71 Million USD | -2024.818% |
| Reviva Pharmaceuticals Holdings, Inc. | 24.3 Million USD | -7305.645% |
| Aadi Bioscience, Inc. | 93.47 Million USD | -1825.652% |
| AnaptysBio, Inc. | 181.56 Million USD | -891.398% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -5218.701% |
| ESSA Pharma Inc. | 32.13 Million USD | -5501.715% |
| Molecular Templates, Inc. | 63.09 Million USD | -2753.119% |
| Scopus BioPharma Inc. | 11.71 Million USD | -15265.599% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | -346.042% |
| Vaxxinity, Inc. | 56.05 Million USD | -3111.47% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -3450.906% |
| Sol-Gel Technologies Ltd. | 30.85 Million USD | -5733.18% |
| Janux Therapeutics, Inc. | 81.06 Million USD | -2120.598% |
| Structure Therapeutics Inc. | 102.77 Million USD | -1651.458% |
| Longboard Pharmaceuticals, Inc. | 56.75 Million USD | -3071.411% |
| Stoke Therapeutics, Inc. | 123.55 Million USD | -1356.914% |
| ImmuCell Corporation | 9.61 Million USD | -18616.785% |
| Lantern Pharma Inc. | 17.87 Million USD | -9968.824% |
| VYNE Therapeutics Inc. | 29.68 Million USD | -5964.487% |
| Ocuphire Pharma, Inc. | 29.6 Million USD | -5980.055% |
| Opthea Limited | 191.96 Million USD | -837.691% |
| Avidity Biosciences, Inc. | 245.15 Million USD | -634.245% |
| Syros Pharmaceuticals, Inc. | 30.77 Million USD | -5749.862% |
| Fate Therapeutics, Inc. | 254.04 Million USD | -608.563% |
| Inhibrx Biosciences, Inc. | 219.83 Million USD | -718.842% |
| Catalyst Pharmaceuticals, Inc. | 259.42 Million USD | -593.866% |
| Orchestra BioMed Holdings, Inc. | 54.08 Million USD | -3228.515% |
| Alzamend Neuro, Inc. | 9.93 Million USD | -18013.557% |
| Rocket Pharmaceuticals, Inc. | 259.65 Million USD | -593.24% |
| Aptose Biosciences Inc. | 52.35 Million USD | -3338.118% |
| ZyVersa Therapeutics, Inc. | 14.41 Million USD | -12391.425% |
| Soligenix, Inc. | 7.79 Million USD | -22991.764% |
| Century Therapeutics, Inc. | 56.07 Million USD | -3110.324% |
| Kura Oncology, Inc. | 165.8 Million USD | -985.656% |
| TScan Therapeutics, Inc. | 114.5 Million USD | -1472.01% |
| Intensity Therapeutics, Inc. | 8.31 Million USD | -21537.949% |
| Ocean Biomedical, Inc. | 2.48 Million USD | -72435.167% |
| CytomX Therapeutics, Inc. | 107.69 Million USD | -1571.397% |
| Autolus Therapeutics plc | 196.72 Million USD | -815.009% |
| Mineralys Therapeutics, Inc. | 84.65 Million USD | -2026.299% |
| EyePoint Pharmaceuticals, Inc. | 116.45 Million USD | -1445.74% |
| Eterna Therapeutics Inc. | 19.38 Million USD | -9186.803% |
| Adaptive Biotechnologies Corporation | 321.75 Million USD | -459.446% |
| GRI Bio, Inc. | 11.33 Million USD | -15787.564% |
| Xenetic Biosciences, Inc. | 7.05 Million USD | -25412.15% |
| Tenaya Therapeutics, Inc. | 131.19 Million USD | -1272.071% |
| IGM Biosciences, Inc. | 265.59 Million USD | -577.757% |
| INmune Bio, Inc. | 29.89 Million USD | -5921.076% |
| Heron Therapeutics, Inc. | 172.55 Million USD | -943.187% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -4365.067% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -11164.912% |
| Entero Therapeutics, Inc. | 15.74 Million USD | -11335.092% |
| Milestone Pharmaceuticals Inc. | 62.09 Million USD | -2798.742% |
| X4 Pharmaceuticals, Inc. | 107.52 Million USD | -1574.133% |
| Atara Biotherapeutics, Inc. | 275.69 Million USD | -552.922% |
| Coherus BioSciences, Inc. | 301.45 Million USD | -497.132% |
| Verastem, Inc. | 92.08 Million USD | -1854.803% |
| Abeona Therapeutics Inc. | 17.93 Million USD | -9934.344% |
| Pliant Therapeutics, Inc. | 185.72 Million USD | -869.208% |
| Tonix Pharmaceuticals Holding Corp. | 121.4 Million USD | -1382.667% |
| Histogen Inc. | 14.27 Million USD | -12512.535% |
| Aprea Therapeutics, Inc. | 16.04 Million USD | -11116.632% |
| Surrozen, Inc. | 18.55 Million USD | -9603.833% |
| Organovo Holdings, Inc. | 14.91 Million USD | -11968.797% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -35263.017% |
| Ovid Therapeutics Inc. | 59.67 Million USD | -2916.534% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -6918.603% |
| CASI Pharmaceuticals, Inc. | 47 Million USD | -3729.428% |
| Cadrenal Therapeutics, Inc. Common Stock | 7.63 Million USD | -23483.1% |
| Centessa Pharmaceuticals plc | 178.13 Million USD | -910.498% |
| Hepion Pharmaceuticals, Inc. | 48.44 Million USD | -3615.453% |
| Arcturus Therapeutics Holdings Inc. | 245 Million USD | -634.707% |
| BioRestorative Therapies, Inc. | 15.36 Million USD | -11614.134% |
| Apollomics, Inc. | 54.14 Million USD | -3224.826% |
| Amarin Corporation plc | 272.35 Million USD | -560.92% |
| Mesoblast Limited | 5.9 Million USD | -30399.17% |
| Turnstone Biologics Corp. | 78.33 Million USD | -2197.813% |
| Kymera Therapeutics, Inc. | 244.12 Million USD | -637.361% |
| Synaptogenix, Inc. | 8.31 Million USD | -21551.342% |
| Tiziana Life Sciences Ltd | 14.58 Million USD | -12241.019% |
| Aurinia Pharmaceuticals Inc. | 253.05 Million USD | -611.329% |
| BriaCell Therapeutics Corp. | 33.33 Million USD | -5300.711% |
| Monopar Therapeutics Inc. | 8.83 Million USD | -20282.891% |
| Exelixis, Inc. | 1.58 Billion USD | -13.441% |
| Better Therapeutics, Inc. | 38.26 Million USD | -4604.566% |
| Nurix Therapeutics, Inc. | 232.05 Million USD | -675.721% |
| Apellis Pharmaceuticals, Inc. | 855.2 Million USD | -110.484% |
| NLS Pharmaceutics AG | 11.8 Million USD | -15145.629% |
| Dermata Therapeutics, Inc. | 8.04 Million USD | -22283.512% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -5901.604% |
| Gritstone bio, Inc. | 148.37 Million USD | -1113.192% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2514.05% |
| TNF Pharmaceuticals, Inc. | 16.36 Million USD | -10902.671% |
| Avid Bioservices, Inc. | 25.99 Million USD | -6824.377% |
| Insmed Incorporated | 949.26 Million USD | -89.628% |
| Virpax Pharmaceuticals, Inc. | 15.68 Million USD | -11372.819% |
| MediWound Ltd. | 18.86 Million USD | -9440.285% |
| OmniAb, Inc. | 83.89 Million USD | -2045.612% |
| Alector, Inc. | 248.8 Million USD | -623.491% |
| Seres Therapeutics, Inc. | 234.3 Million USD | -668.246% |
| Checkpoint Therapeutics, Inc. | 52.25 Million USD | -3345.027% |
| Zai Lab Limited | 547.47 Million USD | -228.793% |
| Revance Therapeutics, Inc. | 398.65 Million USD | -351.535% |
| Aura Biosciences, Inc. | 84.99 Million USD | -2017.943% |
| Lyell Immunopharma, Inc. | 247.13 Million USD | -628.363% |
| Immunic, Inc. | 99.22 Million USD | -1714.157% |
| Tarsus Pharmaceuticals, Inc. | 159.01 Million USD | -1032.028% |
| Veracyte, Inc. | 357.93 Million USD | -402.904% |
| InMed Pharmaceuticals Inc. | 9.01 Billion USD | 80.034% |
| FibroGen, Inc. | 398.11 Million USD | -352.148% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -12567.565% |
| Adial Pharmaceuticals, Inc. | 6.88 Million USD | -26033.491% |
| Sonnet BioTherapeutics Holdings, Inc. | 7.12 Million USD | -25161.419% |
| Jazz Pharmaceuticals plc | 3.25 Billion USD | 44.709% |
| Cyclacel Pharmaceuticals, Inc. | 25.87 Million USD | -6857.295% |
| Amylyx Pharmaceuticals, Inc. | 316.54 Million USD | -468.662% |
| TG Therapeutics, Inc. | 198.47 Million USD | -806.946% |
| Galecto, Inc. | 35.62 Million USD | -4952.519% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -4323.95% |
| Fortrea Holdings Inc. | 457.3 Million USD | -293.628% |
| KalVista Pharmaceuticals, Inc. | 54.27 Million USD | -3216.373% |
| Aptevo Therapeutics Inc. | 28.87 Million USD | -6133.33% |
| XBiotech Inc. | 37.51 Million USD | -4698.883% |
| Jasper Therapeutics, Inc. | 68.86 Million USD | -2514.05% |
| Lyra Therapeutics, Inc. | 20.64 Million USD | -8617.425% |
| Foghorn Therapeutics Inc. | 142.06 Million USD | -1167.104% |
| Y-mAbs Therapeutics, Inc. | 99.07 Million USD | -1716.867% |
| Theravance Biopharma, Inc. | 110.71 Million USD | -1525.836% |
| Ultragenyx Pharmaceutical Inc. | 958.24 Million USD | -87.849% |
| Metagenomi, Inc. Common Stock | 28.84 Million USD | -6140.461% |
| BioCryst Pharmaceuticals, Inc. | 430.64 Million USD | -317.997% |
| Gain Therapeutics, Inc. | 22.3 Million USD | -7969.014% |
| Cartesian Therapeutics, Inc. | 110.86 Million USD | -1523.622% |
| NexImmune, Inc. | 28.16 Million USD | -6290.558% |
| Creative Medical Technology Holdings, Inc. | 5.53 Million USD | -32445.253% |
| Marker Therapeutics, Inc. | 17.89 Million USD | -9960.416% |
| Regeneron Pharmaceuticals, Inc. | 2.81 Billion USD | 36.061% |
| Chemomab Therapeutics Ltd. | 25.45 Million USD | -6970.431% |
| RAPT Therapeutics, Inc. | 127.06 Million USD | -1316.679% |
| Ainos, Inc. | 12.95 Million USD | -13797.227% |
| Pluri Inc. | 22.48 Million USD | -7907.389% |
| Prothena Corporation plc | 282.4 Million USD | -537.402% |
| Adaptimmune Therapeutics plc | 200.02 Million USD | -799.932% |
| Celularity Inc. | 215.05 Million USD | -737.012% |
| Rallybio Corporation | 78.93 Million USD | -2180.521% |
| Cue Biopharma, Inc. | 19.54 Million USD | -9111.242% |
| MeiraGTx Holdings plc | 151.07 Million USD | -1091.478% |
| Omeros Corporation | 94.75 Million USD | -1799.78% |
| Humacyte, Inc. | 23.49 Million USD | -7560.812% |
| Immunocore Holdings plc | 308.04 Million USD | -484.359% |
| Cocrystal Pharma, Inc. | 3.39 Million USD | -52999.145% |
| Cidara Therapeutics, Inc. | 86.86 Million USD | -1972.251% |
| Blueprint Medicines Corporation | 722.86 Million USD | -149.019% |
| CalciMedica, Inc. | 21.81 Million USD | -8150.726% |
| Cabaletta Bio, Inc. | 74.66 Million USD | -2311.011% |
| Scholar Rock Holding Corporation | 171.29 Million USD | -950.854% |
| Sana Biotechnology, Inc. | 294.94 Million USD | -510.314% |
| Pulmatrix, Inc. | 22.03 Million USD | -8067.987% |
| Elicio Therapeutics, Inc. | 34.57 Million USD | -5106.25% |
| Vigil Neuroscience, Inc. | 88.86 Million USD | -1925.59% |
| Intellia Therapeutics, Inc. | 551.56 Million USD | -226.355% |
| Adlai Nortye Ltd. American Depositary Shares | 72.55 Million USD | -2381.097% |
| Cytokinetics, Incorporated | 173.61 Million USD | -936.83% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -5129.847% |
| Nutriband Inc. | 5.73 Million USD | -31292.593% |
| Protara Therapeutics, Inc. | 43.61 Million USD | -4027.35% |
| Vor Biopharma Inc. | 126.03 Million USD | -1328.212% |
| Roivant Sciences Ltd. | 1.18 Billion USD | -51.37% |
| Evogene Ltd. | 27.79 Million USD | -6377.37% |
| ProKidney Corp. | 151.52 Million USD | -1087.987% |
| Applied Therapeutics, Inc. | 74.17 Million USD | -2326.776% |
| Hoth Therapeutics, Inc. | 7.69 Million USD | -23300.993% |
| BridgeBio Pharma, Inc. | 614.22 Million USD | -193.061% |
| CorMedix Inc. | 48.95 Million USD | -3576.761% |
| BioLineRx Ltd. | 50.8 Million USD | -3443.288% |
| Tango Therapeutics, Inc. | 150.7 Million USD | -1094.466% |
| Galectin Therapeutics Inc. | 38.07 Million USD | -4628.044% |
| Atai Life Sciences N.V. | 125.78 Million USD | -1331.062% |
| Renovaro Biosciences Inc. | 81.63 Million USD | -2104.895% |
| Aerovate Therapeutics, Inc. | 81.4 Million USD | -2111.133% |
| Zentalis Pharmaceuticals, Inc. | 252.55 Million USD | -612.749% |
| Sagimet Biosciences Inc. | 32.74 Million USD | -5398.048% |
| MediciNova, Inc. | 10.9 Million USD | -16413.92% |
| Praxis Precision Medicines, Inc. | 128.82 Million USD | -1297.346% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -24695.854% |
| GeoVax Labs, Inc. | 6.02 Million USD | -29790.556% |
| Axsome Therapeutics, Inc. | 476.36 Million USD | -277.878% |
| Biomea Fusion, Inc. | 126.13 Million USD | -1327.091% |
| PTC Therapeutics, Inc. | 1.31 Billion USD | -37.217% |
| Mereo BioPharma Group plc | 35.84 Million USD | -4922.211% |
| Cullinan Oncology, Inc. | 191.08 Million USD | -842.001% |
| Absci Corporation | 73.66 Million USD | -2343.544% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -6426.216% |
| 4D Molecular Therapeutics, Inc. | 133.59 Million USD | -1247.452% |
| Dyne Therapeutics, Inc. | 242.16 Million USD | -643.329% |
| Kiniksa Pharmaceuticals, Ltd. | 262.04 Million USD | -586.92% |
| Ventyx Biosciences, Inc. | 207.99 Million USD | -765.439% |
| Allakos Inc. | 196.05 Million USD | -818.136% |
| Imunon, Inc. | 20.31 Million USD | -8762.744% |
| Fulcrum Therapeutics, Inc. | 113.46 Million USD | -1486.39% |
| Corcept Therapeutics Incorporated | 368.61 Million USD | -388.335% |
| BioAtla, Inc. | 129.68 Million USD | -1288.004% |
| NLS Pharmaceutics AG | 11.8 Million USD | -15145.629% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -11261.87% |
| Allogene Therapeutics, Inc. | 84.91 Million USD | -2019.764% |
| Larimar Therapeutics, Inc. | 41.75 Million USD | -4210.697% |
| XOMA Corporation | 46.46 Million USD | -3774.182% |
| Kezar Life Sciences, Inc. | 111.17 Million USD | -1519.182% |
| Cara Therapeutics, Inc. | 142.46 Million USD | -1163.529% |
| aTyr Pharma, Inc. | 12.97 Million USD | -13769.027% |
| Aligos Therapeutics, Inc. | 103.65 Million USD | -1636.572% |
| Akero Therapeutics, Inc. | 172.87 Million USD | -941.28% |
| Viridian Therapeutics, Inc. | 254.76 Million USD | -606.56% |
| Eliem Therapeutics, Inc. | 37.4 Million USD | -4711.968% |
| EyeGate Pharmaceuticals, Inc. | 8.22 Million USD | -21785.735% |
| Akari Therapeutics, Plc | 16.8 Million USD | -10610.824% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -79059.4% |
| Halozyme Therapeutics, Inc. | 299.31 Million USD | -501.387% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -26651.868% |
| UroGen Pharma Ltd. | 138.88 Million USD | -1196.052% |
| Sutro Biopharma, Inc. | 243 Million USD | -640.738% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -24644.392% |
| Orgenesis Inc. | 45.75 Million USD | -3833.958% |
| Entera Bio Ltd. | 8.86 Million USD | -20216.716% |
| GH Research PLC | 41.22 Million USD | -4266.748% |
| Lisata Therapeutics, Inc. | 25.7 Million USD | -6901.949% |
| Reneo Pharmaceuticals, Inc. | 83.05 Million USD | -2067.364% |
| Xencor, Inc. | 306.97 Million USD | -486.383% |
| 60 Degrees Pharmaceuticals, Inc. | 4.93 Million USD | -36385.706% |
| Replimune Group, Inc. | 234.77 Million USD | -666.724% |
| Coeptis Therapeutics Holdings, Inc. | 20.48 Million USD | -8685.119% |
| Vanda Pharmaceuticals Inc. | 191.79 Million USD | -838.529% |
| Lexaria Bioscience Corp. | 6.72 Million USD | -26651.868% |
| Portage Biotech Inc. | 18.19 Million USD | -9790.989% |
| Cardio Diagnostics Holdings, Inc. | 7.25 Million USD | -24695.854% |
| Olema Pharmaceuticals, Inc. | 104.96 Million USD | -1614.981% |
| OncoCyte Corporation | 25.63 Million USD | -6921.34% |
| Qualigen Therapeutics, Inc. | 6.09 Million USD | -29430.463% |
| Processa Pharmaceuticals, Inc. | 11.45 Million USD | -15611.368% |
| Purple Biotech Ltd. | -22.46 Million USD | 8112.022% |
| CollPlant Biotechnologies Ltd. | 16.48 Million USD | -10822.7% |
| scPharmaceuticals Inc. | 65.17 Million USD | -2661.762% |
| ProMIS Neurosciences, Inc. | 8.45 Million USD | -21195.602% |
| HilleVax, Inc. | 133.34 Million USD | -1249.928% |
| NeuroSense Therapeutics Ltd. | 10.28 Million USD | -17401.808% |
| Tharimmune, Inc. | 9.45 Million USD | -18937.748% |
| Genprex, Inc. | 31.06 Million USD | -5695.326% |
| Neumora Therapeutics, Inc. Common Stock | 187.52 Million USD | -859.899% |
| Atossa Therapeutics, Inc. | 31.37 Million USD | -5636.881% |
| XTL Biopharmaceuticals Ltd. | 765 Thousand USD | -235202.092% |
| Virios Therapeutics, Inc. | 5.44 Million USD | -32947.325% |
| OKYO Pharma Limited | 8243.57 USD | -21835840.011% |
| Savara Inc. | 15.74 Million USD | -11332.588% |
| Curis, Inc. | 58.35 Million USD | -2984.673% |
| Daré Bioscience, Inc. | 33.6 Million USD | -5255.826% |
| Carmell Therapeutics Corporation | 5.09 Million USD | -35247.378% |
| Titan Pharmaceuticals, Inc. | 7.46 Million USD | -24026.27% |
| Achieve Life Sciences, Inc. | 27.02 Million USD | -6561.465% |
| BeiGene, Ltd. | 3.28 Billion USD | 45.23% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -8927.704% |
| Revolution Medicines, Inc. Warrant | 498.76 Million USD | -260.904% |
| Protagonist Therapeutics, Inc. | 153.65 Million USD | -1071.518% |
| Erasca, Inc. | 141.52 Million USD | -1171.903% |
| bluebird bio, Inc. | 240.23 Million USD | -649.301% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -39663.007% |
| BioMarin Pharmaceutical Inc. | 1.74 Billion USD | -3.08% |
| DBV Technologies S.A. | 92.16 Million USD | -1853.191% |
| Protagenic Therapeutics, Inc. | 4.52 Million USD | -39663.007% |
| Moderna, Inc. | 6.39 Billion USD | 71.848% |
| Vincerx Pharma, Inc. | 42.6 Million USD | -4124.603% |
| Fresh Tracks Therapeutics, Inc. | 14.36 Million USD | -12430.008% |
| Acrivon Therapeutics, Inc. Common Stock | 66.7 Million USD | -2598.702% |
| Travere Therapeutics, Inc. | 472 Million USD | -281.367% |
| Monte Rosa Therapeutics, Inc. | 143.31 Million USD | -1156.052% |
| Spruce Biosciences, Inc. | 62.08 Million USD | -2799.489% |
| Celldex Therapeutics, Inc. | 43.41 Million USD | -4046.268% |
| Cogent Biosciences, Inc. | 208.13 Million USD | -764.873% |
| MacroGenics, Inc. | 217.21 Million USD | -728.7% |
| RenovoRx, Inc. | 11.39 Million USD | -15695.551% |
| Adicet Bio, Inc. | 152.03 Million USD | -1083.955% |
| Prime Medicine, Inc. | 186.63 Million USD | -864.461% |
| Aditxt, Inc. | 25.95 Million USD | -6836.447% |
| Adagene Inc. | 41.83 Million USD | -4203.138% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -24524.307% |
| Quantum-Si incorporated | 111.65 Million USD | -1512.106% |
| Maravai LifeSciences Holdings, Inc. | 171.85 Million USD | -947.461% |
| Acurx Pharmaceuticals, Inc. | 14.57 Million USD | -12247.988% |
| Voyager Therapeutics, Inc. | 35.82 Million USD | -4925.015% |
| SciSparc Ltd. | 9.01 Million USD | -19876.262% |
| Vericel Corporation | 142.04 Million USD | -1167.292% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -20693.934% |
| Minerva Neurosciences, Inc. | 23.08 Million USD | -7696.321% |
| Generation Bio Co. | 144.46 Million USD | -1146.002% |
| Astria Therapeutics, Inc. | 83.03 Million USD | -2067.965% |
| Black Diamond Therapeutics, Inc. | 86.46 Million USD | -1981.958% |
| Arcutis Biotherapeutics, Inc. | 295.72 Million USD | -508.705% |
| Invivyd, Inc. | 205.75 Million USD | -774.857% |
| Relay Therapeutics, Inc. | 72.15 Million USD | -2394.576% |
| Quoin Pharmaceuticals, Ltd. | 9.37 Million USD | -19093.477% |
| Spero Therapeutics, Inc. | 75.25 Million USD | -2291.98% |
| Artelo Biosciences, Inc. | 10.28 Million USD | -17398.406% |
| 2seventy bio, Inc. | 289.88 Million USD | -520.953% |
| ADMA Biologics, Inc. | 66.58 Million USD | -2603.363% |
| Clene Inc. | 41.07 Million USD | -4282.59% |
| Capricor Therapeutics, Inc. | 12.8 Million USD | -13954.318% |
| Boundless Bio, Inc. Common Stock | 54.79 Million USD | -3185.023% |
| GeoVax Labs, Inc. | 6.02 Million USD | -29790.556% |
| Recursion Pharmaceuticals, Inc. | 352.04 Million USD | -411.311% |
| Citius Pharmaceuticals, Inc. | 36.73 Million USD | -4800.523% |
| Contineum Therapeutics, Inc. Class A Common Stock | 33.72 Million USD | -5236.993% |
| Relmada Therapeutics, Inc. | 103.7 Million USD | -1635.802% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -5423.523% |
| ALX Oncology Holdings Inc. | 170.27 Million USD | -957.131% |
| Vir Biotechnology, Inc. | 767.72 Million USD | -134.468% |
| Evaxion Biotech A/S | 22.27 Million USD | -7982.896% |
| Ocular Therapeutix, Inc. | 135.54 Million USD | -1228.027% |
| Verve Therapeutics, Inc. | 234.88 Million USD | -666.368% |
| Trevena, Inc. | 38.41 Million USD | -4586.072% |
| Surrozen, Inc. | 18.55 Million USD | -9603.833% |
| Tyra Biosciences, Inc. | 79.94 Million USD | -2151.624% |
| Cingulate Inc. | 22.75 Million USD | -7809.161% |
| Galmed Pharmaceuticals Ltd. | -7.49 Million USD | 24126.442% |
| Unity Biotechnology, Inc. | 44.66 Million USD | -3929.957% |
| Tenax Therapeutics, Inc. | 8.23 Million USD | -21761.476% |
| Terns Pharmaceuticals, Inc. | 102.55 Million USD | -1655.164% |
| ACADIA Pharmaceuticals Inc. | 754.08 Million USD | -138.708% |
| Connect Biopharma Holdings Limited | 62.07 Million USD | -2799.863% |
| Clearmind Medicine Inc. | 8.74 Million USD | -20492.483% |
| Kronos Bio, Inc. | 128.11 Million USD | -1305.002% |
| Bolt Biotherapeutics, Inc. | 84.07 Million USD | -2041.095% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -61273.004% |
| Viking Therapeutics, Inc. | 100.82 Million USD | -1685.297% |
| Statera Biopharma, Inc. | 28.82 Million USD | -6143.815% |
| ImmunityBio, Inc. | 362.87 Million USD | -396.059% |
| Korro Bio, Inc. | 84.53 Million USD | -2029.393% |
| Kineta, Inc. | 21.15 Million USD | -8408.513% |
| BioVie Inc. | 31.95 Million USD | -5533.957% |
| Codexis, Inc. | 66.51 Million USD | -2606.126% |
| Celularity Inc. | 215.05 Million USD | -737.012% |
| Crinetics Pharmaceuticals, Inc. | 226.62 Million USD | -694.305% |
| Celcuity Inc. | 66.23 Million USD | -2617.88% |
| Virax Biolabs Group Limited | 6.54 Million USD | -27394.176% |
| Cibus, Inc. | 320.3 Million USD | -461.983% |
| Eledon Pharmaceuticals, Inc. | 43 Million USD | -4086.188% |
| IN8bio, Inc. | 30.33 Million USD | -5833.55% |
| Kodiak Sciences Inc. | 277.32 Million USD | -549.089% |
| Annexon, Inc. | 143.72 Million USD | -1152.452% |
| Adverum Biotechnologies, Inc. | 127.59 Million USD | -1310.806% |
| Assembly Biosciences, Inc. | 22.9 Million USD | -7757.44% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -281159.531% |
| Ionis Pharmaceuticals, Inc. | 779.58 Million USD | -130.899% |
| Eyenovia, Inc. | 25.4 Million USD | -6985.056% |
| Puma Biotechnology, Inc. | 140.31 Million USD | -1182.871% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -32263.556% |
| Xilio Therapeutics, Inc. | 79.13 Million USD | -2174.729% |
| Arcellx, Inc. | 200.19 Million USD | -799.136% |
| Cardiff Oncology, Inc. | 45.9 Million USD | -3821.702% |
| Enanta Pharmaceuticals, Inc. | 216.41 Million USD | -731.779% |
| Regulus Therapeutics Inc. | 9.95 Million USD | -17978.347% |
| Moolec Science SA | 52.75 Million USD | -3312.399% |
| Acumen Pharmaceuticals, Inc. | 61.13 Million USD | -2844.259% |
| LAVA Therapeutics N.V. | 46.54 Million USD | -3767.772% |
| Royalty Pharma plc | 862.4 Million USD | -108.726% |
| Atea Pharmaceuticals, Inc. | 94.07 Million USD | -1813.493% |
| Greenwich LifeSciences, Inc. | 9.32 Million USD | -19197.672% |
| TFF Pharmaceuticals, Inc. | 22.62 Million USD | -7854.829% |
| Mersana Therapeutics, Inc. | 207.81 Million USD | -766.197% |
| Humacyte, Inc. | 23.49 Million USD | -7560.812% |
| 89bio, Inc. | 151.2 Million USD | -1090.485% |
| PMV Pharmaceuticals, Inc. | 80.13 Million USD | -2146.37% |
| Avenue Therapeutics, Inc. | 14.54 Million USD | -12280.062% |
| Genelux Corporation | 24.33 Million USD | -7297.004% |
| Trevi Therapeutics, Inc. | 33.92 Million USD | -5206.314% |
| Lexicon Pharmaceuticals, Inc. | 172.86 Million USD | -941.286% |
| Notable Labs, Ltd. | 14.77 Million USD | -12087.278% |
| Liquidia Corporation | 87.98 Million USD | -1945.896% |
| Mustang Bio, Inc. | 48.5 Million USD | -3611.389% |
| Immunovant, Inc. | 282.7 Million USD | -536.719% |
| Quantum-Si incorporated | 111.65 Million USD | -1512.106% |
| Arbutus Biopharma Corporation | 22.54 Million USD | -7884.657% |
| DiaMedica Therapeutics Inc. | 21.26 Million USD | -8364.104% |
| Vera Therapeutics, Inc. | 102.01 Million USD | -1664.558% |
| Acasti Pharma Inc. | 11.3 Million USD | -15828.334% |
| MiNK Therapeutics, Inc. | 22.92 Million USD | -7753.291% |
| Pasithea Therapeutics Corp. | 15.97 Million USD | -11164.912% |
| Xenon Pharmaceuticals Inc. | 46.54 Million USD | -3767.606% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -158554.392% |
| NeuroBo Pharmaceuticals, Inc. | 15.88 Million USD | -11231.115% |
| Tempest Therapeutics, Inc. | 29.15 Million USD | -6073.684% |
| Soleno Therapeutics, Inc. | 41.38 Million USD | -4249.654% |
| PepGen Inc. | 84.76 Million USD | -2023.565% |
| Moleculin Biotech, Inc. | 29.63 Million USD | -5974.925% |
| United Therapeutics Corporation | 885.1 Million USD | -103.374% |
| Nuvectis Pharma, Inc. | 22.89 Million USD | -7761.558% |
| Solid Biosciences Inc. | 104.31 Million USD | -1625.601% |
| BriaCell Therapeutics Corp. | 32.72 Million USD | -5400.479% |
| Immuneering Corporation | 58.41 Million USD | -2981.616% |
| Lixte Biotechnology Holdings, Inc. | 5.09 Million USD | -35263.017% |
| Silo Pharma, Inc. | 3.92 Million USD | -45798.192% |
| Belite Bio, Inc | 31.66 Million USD | -5584.164% |
| XOMA Corporation | 46.46 Million USD | -3774.182% |
| ARS Pharmaceuticals, Inc. | 67.55 Million USD | -2564.783% |
| Bionomics Limited | 17.89 Billion USD | 89.94% |
| Apogee Therapeutics, Inc. | 93 Million USD | -1835.487% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 5145.014% |
| uniQure N.V. | 285.08 Million USD | -531.41% |
| Cassava Sciences, Inc. | 105.95 Million USD | -1598.86% |
| Estrella Immunopharma, Inc. | 7.31 Million USD | -24524.307% |
| Poseida Therapeutics, Inc. | 194.2 Million USD | -826.878% |
| Forte Biosciences, Inc. | 32.47 Million USD | -5442.572% |
| Anebulo Pharmaceuticals, Inc. | 8.3 Million USD | -21564.63% |
| Enlivex Therapeutics Ltd. | 29.39 Million USD | -6023.698% |
| Conduit Pharmaceuticals Inc. | 5.56 Million USD | -32263.556% |
| SeaStar Medical Holding Corporation | 14.21 Million USD | -12567.565% |
| FibroBiologics, Inc. Common Stock | 8.88 Million USD | -20150.433% |
| Altimmune, Inc. | 30.55 Million USD | -5791.023% |
| Amicus Therapeutics, Inc. | 427.65 Million USD | -320.918% |
| Alpha Tau Medical Ltd. | -35.68 Million USD | 5145.014% |
| Compugen Ltd. | 43.97 Million USD | -3993.746% |
| Peak Bio, Inc. | 1249.13 USD | -144105077.203% |
| Zevra Therapeutics, Inc. | 74.12 Million USD | -2328.577% |
| Benitec Biopharma Inc. | 22.38 Million USD | -7942.449% |
| Spyre Therapeutics, Inc. | 243.18 Million USD | -640.19% |
| NKGen Biotech, Inc. Common Stock | 28.54 Million USD | -6206.488% |
| Zura Bio Limited | 62.63 Million USD | -2773.752% |
| PolyPid Ltd. | 21.04 Million USD | -8453.39% |
| Aileron Therapeutics, Inc. | 16.27 Million USD | -10959.603% |
| NKGen Biotech, Inc. Warrants | 28.54 Million USD | -6206.488% |
| Instil Bio, Inc. | 85.78 Million USD | -1998.34% |
| argenx SE | 1.53 Billion USD | -17.38% |
| Immunome, Inc. | 122.82 Million USD | -1365.609% |
| Compass Therapeutics, Inc. | 48.47 Million USD | -3613.533% |
| Verona Pharma plc | 67.15 Million USD | -2580.606% |
| enGene Holdings Inc. Warrants | 25.88 Million USD | -6854.07% |
| Shattuck Labs, Inc. | 93.61 Million USD | -1822.854% |
| CervoMed Inc. | 14.95 Million USD | -11934.29% |
| LENZ Therapeutics, Inc. | 70.7 Million USD | -2445.947% |
| Plus Therapeutics, Inc. | 8.54 Million USD | -20968.13% |
| Dianthus Therapeutics, Inc. | 51 Million USD | -3429.531% |
| Moolec Science SA | 52.75 Million USD | -3312.399% |
| Enveric Biosciences, Inc. | 16.44 Million USD | -10843.658% |
| Inovio Pharmaceuticals, Inc. | 132.55 Million USD | -1257.972% |
| Design Therapeutics, Inc. | 78.19 Million USD | -2202.163% |
| Leap Therapeutics, Inc. | 87.04 Million USD | -1968.061% |
| NeurAxis, Inc. | 8.82 Million USD | -20306.081% |
| Seelos Therapeutics, Inc. | 12.58 Million USD | -14203.226% |
| Lumos Pharma, Inc. | 38.66 Million USD | -4555.531% |
| Achilles Therapeutics plc | 75.25 Million USD | -2291.949% |
| enGene Holdings Inc. Common Stock | 25.88 Million USD | -6854.07% |
| 180 Life Sciences Corp. | 13.47 Million USD | -13256.045% |
| Opiant Pharmaceuticals, Inc. | 26.5 Million USD | -6692.057% |
| CERo Therapeutics Holdings, Inc. | 2.93 Million USD | -61273.004% |
| Nutriband Inc. | 5.73 Million USD | -31292.593% |
| ORIC Pharmaceuticals, Inc. | 110.78 Million USD | -1524.897% |
| CG Oncology, Inc. Common stock | 55.65 Million USD | -3134.437% |
| Fractyl Health, Inc. Common Stock | 50.87 Million USD | -3437.925% |
| Rani Therapeutics Holdings, Inc. | 66.09 Million USD | -2623.28% |
| MoonLake Immunotherapeutics | 54.12 Million USD | -3225.865% |
| Palisade Bio, Inc. | 13.32 Million USD | -13413.971% |
| Tourmaline Bio, Inc. | 45.4 Million USD | -3864.106% |
| Beam Therapeutics Inc. | 554.19 Million USD | -224.807% |
| Neurogene Inc. | 55.58 Million USD | -3138.51% |
| Mirum Pharmaceuticals, Inc. | 248.48 Million USD | -624.403% |
| AEON Biopharma, Inc. | 48.42 Million USD | -3616.907% |
| Sesen Bio, Inc. | 78.38 Million USD | -2196.553% |
| Enliven Therapeutics, Inc. | 83.52 Million USD | -2055.013% |
| Kiora Pharmaceuticals, Inc. | 12.58 Million USD | -14201.072% |
| Iovance Biotherapeutics, Inc. | 450.99 Million USD | -299.133% |
| Taysha Gene Therapies, Inc. | 87.89 Million USD | -1948.084% |
| Athira Pharma, Inc. | 125.46 Million USD | -1334.7% |
| Vaccinex, Inc. | 23.45 Million USD | -7574.53% |
| HCW Biologics Inc. | 21.02 Million USD | -8460.501% |
| XOMA Corporation | 46.46 Million USD | -3774.182% |
| Nektar Therapeutics | 190.9 Million USD | -842.919% |
| Arvinas, Inc. | 480 Million USD | -275.013% |
| Tevogen Bio Holdings Inc. | 2.27 Million USD | -79059.4% |
| Merus N.V. | 200.49 Million USD | -797.813% |
| Omega Therapeutics, Inc. | 103.35 Million USD | -1641.629% |
| Quince Therapeutics, Inc. | 34.62 Million USD | -5099.483% |
| Rezolute, Inc. | 70.38 Million USD | -2457.377% |
| Clene Inc. | 41.07 Million USD | -4282.59% |
| Indaptus Therapeutics, Inc. | 16.37 Million USD | -10890.407% |
| BeyondSpring Inc. | 24.86 Million USD | -7139.336% |
| Synlogic, Inc. | 58.53 Million USD | -2975.345% |
| Allarity Therapeutics, Inc. | 17.89 Million USD | -9960.703% |
| Phio Pharmaceuticals Corp. | 4.49 Million USD | -39972.596% |
| Peak Bio, Inc. | 1249.13 USD | -144105077.203% |
| Werewolf Therapeutics, Inc. | 60.44 Million USD | -2877.965% |
| Krystal Biotech, Inc. | 160.42 Million USD | -1022.051% |
| Karyopharm Therapeutics Inc. | 270.63 Million USD | -565.135% |
| SpringWorks Therapeutics, Inc. | 348.03 Million USD | -417.202% |
| Lipella Pharmaceuticals Inc. | 2.15 Million USD | -83362.356% |
| MannKind Corporation | 125.59 Million USD | -1333.204% |
| Ikena Oncology, Inc. | 84.57 Million USD | -2028.31% |
| Cyclerion Therapeutics, Inc. | 9.64 Million USD | -18559.283% |
| Gyre Therapeutics, Inc. | 89.6 Million USD | -1908.974% |
| Gossamer Bio, Inc. | 183.75 Million USD | -879.577% |
| CohBar, Inc. | 12.38 Million USD | -14430.335% |
| Cognition Therapeutics, Inc. | 50.72 Million USD | -3448.736% |
| NRx Pharmaceuticals, Inc. | 27.58 Million USD | -6426.216% |
| Legend Biotech Corporation | 583.14 Million USD | -208.682% |
| Mural Oncology plc | 192.07 Million USD | -837.185% |
| Biora Therapeutics, Inc. | 67.14 Million USD | -2580.777% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -11049.153% |
| Disc Medicine, Inc. | 91.12 Million USD | -1875.376% |
| Champions Oncology, Inc. | 28.11 Million USD | -6303.632% |
| REGENXBIO Inc. | 321.15 Million USD | -460.493% |
| Ensysce Biosciences, Inc. | 5.36 Million USD | -33475.498% |
| Anavex Life Sciences Corp. | 55.75 Million USD | -3128.462% |
| Cellectar Biosciences, Inc. | 38.96 Million USD | -4520.204% |
| Edgewise Therapeutics, Inc. | 114.35 Million USD | -1474.072% |
| Vaxart, Inc. | 90.72 Million USD | -1884.063% |
| PharmaCyte Biotech, Inc. | 8.52 Million USD | -21027.457% |
| Aldeyra Therapeutics, Inc. | 42.79 Million USD | -4106.332% |
| Cellectis S.A. | 97.32 Million USD | -1749.631% |
| Longeveron Inc. | 21.25 Million USD | -8370.875% |
| Repare Therapeutics Inc. | 167.35 Million USD | -975.582% |
| Sarepta Therapeutics, Inc. | 1.36 Billion USD | -32.278% |
| Inozyme Pharma, Inc. | 75.64 Million USD | -2279.617% |
| Revolution Medicines, Inc. | 498.76 Million USD | -260.904% |
| Nymox Pharmaceutical Corporation | 6.65 Million USD | -26960.448% |
| Third Harmonic Bio, Inc. | 43.95 Million USD | -3995.329% |
| ArriVent BioPharma, Inc. Common Stock | 74.59 Million USD | -2313.274% |
| AN2 Therapeutics, Inc. | 69.63 Million USD | -2484.995% |
| Anixa Biosciences, Inc. | 11.06 Million USD | -16175.416% |
| Vertex Pharmaceuticals Incorporated | 4.77 Billion USD | 62.302% |
| Denali Therapeutics Inc. | 527.23 Million USD | -241.419% |
| Revelation Biosciences, Inc. | 8.65 Million USD | -20693.934% |
| Veru Inc. | 101.34 Million USD | -1676.116% |
| Corvus Pharmaceuticals, Inc. | 23.4 Million USD | -7590.268% |
| Cingulate Inc. | 22.75 Million USD | -7809.161% |
| Passage Bio, Inc. | 108.38 Million USD | -1560.741% |
| Context Therapeutics Inc. | 25.07 Million USD | -7079.39% |
| Exicure, Inc. | 14.07 Million USD | -12688.157% |
| Day One Biopharmaceuticals, Inc. | 206.06 Million USD | -773.545% |
| Oramed Pharmaceuticals Inc. | 43.3 Million USD | -4057.089% |
| Scinai Immunotherapeutics Ltd. | 9.17 Million USD | -19514.298% |
| Rhythm Pharmaceuticals, Inc. | 252.48 Million USD | -612.943% |
| Nuvalent, Inc. | 149.49 Million USD | -1104.119% |
| ABVC BioPharma, Inc. | 8.06 Million USD | -22214.155% |
| Carisma Therapeutics, Inc. | 103.65 Million USD | -1636.672% |
| Unicycive Therapeutics, Inc. | 21.44 Million USD | -8292.284% |
| OmniAb, Inc. | 83.89 Million USD | -2045.612% |
| Anew Medical, Inc. | 1.3 Million USD | -138276.712% |
| Fennec Pharmaceuticals Inc. | 32.76 Million USD | -5394.021% |
| Lipocine Inc. | 15.08 Million USD | -11836.634% |
| Lexeo Therapeutics, Inc. Common Stock | 68.51 Million USD | -2527.328% |
| Nautilus Biotechnology, Inc. | 76.15 Million USD | -2263.774% |
| SAB Biotherapeutics, Inc. | 40.31 Million USD | -4365.067% |
| G1 Therapeutics, Inc. | 114.84 Million USD | -1467.41% |
| Bellerophon Therapeutics, Inc. | 22.38 Million USD | -7941.731% |
| Sage Therapeutics, Inc. | 664.14 Million USD | -171.034% |
| Ocugen, Inc. | 71.56 Million USD | -2415.211% |
| Mind Medicine (MindMed) Inc. | 93.86 Million USD | -1817.692% |
| Q32 Bio Inc. | 92.68 Million USD | -1842.232% |
| Brainstorm Cell Therapeutics Inc. | 21.17 Million USD | -8401.28% |
| Alumis Inc. Common Stock | 158.17 Million USD | -1038.026% |
| Equillium, Inc. | 50.6 Million USD | -3457.011% |
| Kyverna Therapeutics, Inc. | 62.4 Million USD | -2784.436% |
| Coya Therapeutics, Inc. | 13.9 Million USD | -12844.906% |
| CNS Pharmaceuticals, Inc. | 18.86 Million USD | -9441.748% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -3733.914% |
| Evelo Biosciences, Inc. | 108.46 Million USD | -1559.562% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -14425.14% |
| Dominari Holdings Inc. | 23.83 Million USD | -7452.175% |
| Edesa Biotech, Inc. | 9.22 Million USD | -19417.6% |
| vTv Therapeutics Inc. | 11.9 Million USD | -15017.67% |
| Bio-Techne Corporation | 563.03 Million USD | -219.704% |
| Agios Pharmaceuticals, Inc. | 408.8 Million USD | -340.322% |
| Harmony Biosciences Holdings, Inc. | 268.75 Million USD | -569.775% |
| Prelude Therapeutics Incorporated | 132.27 Million USD | -1260.827% |
| Candel Therapeutics, Inc. | 14.41 Million USD | -12390.882% |
| iTeos Therapeutics, Inc. | 163.69 Million USD | -999.637% |
| Nkarta, Inc. | 131.65 Million USD | -1267.308% |
| BioCardia, Inc. | 12.12 Million USD | -14750.763% |
| Iterum Therapeutics plc | 47.46 Million USD | -3692.157% |